The Role of Different Supplements in Expression Level of Monoclonal Antibody against Human CD20

BACKGROUND: Recombinant monoclonal antibodies have been marketed in last three decades as the major therapeutic proteins against different cancers. However choosing a proper medium and supplements to reach the high expression is a challenging step. Despite of commercial serum free and chemically def...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahboudi, Fereidoun, Abolhassan, Mohammad Reza, Azarpanah, Armita, Aghajani-Lazarjani, Hamideh, Sadeghi-Haskoo, Mohammad Amin, Maleknia, Shaian, Vaziri, Behrouz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732863/
https://www.ncbi.nlm.nih.gov/pubmed/23919117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732863/
https://www.ncbi.nlm.nih.gov/pubmed/23919117

Ejemplares similares